Next-Generation Synthetic Biology Workflow Platform
Codex DNA’s BioXp 9600 system is designed for the automated synthesis of synthetic biology workflows.
Codex DNA’s BioXp 9600 System
Codex DNA’s BioXp 9600 system is a next-generation high throughput platform intended for automated synthesis of gene fragments and clones from digital sequences. Designed for use with synthetic biology workflows, the system provides overnight, automated synthesis of genes, clones, DNA libraries, and mRNA. It is capable of processing up to 96 gene fragments overnight.
The system features a unique instrument design that is intended to minimize benchtop footprint while also increasing throughput and versatility. Proprietary error correction and Gibson assembly technology automate the identification and removal of mismatches introduced during synthesis and assembly.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications
December 10th 2024This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.
